Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioRestorative Therapies (BRTX) Revenue (2016 - 2025)

Historic Revenue for BioRestorative Therapies (BRTX) over the last 15 years, with Q3 2025 value amounting to $11800.0.

  • BioRestorative Therapies' Revenue fell 9494.86% to $11800.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $383400.0, marking a year-over-year increase of 169.76%. This contributed to the annual value of $401000.0 for FY2024, which is 17503.43% up from last year.
  • BioRestorative Therapies' Revenue amounted to $11800.0 in Q3 2025, which was down 9494.86% from $303300.0 recorded in Q2 2025.
  • In the past 5 years, BioRestorative Therapies' Revenue registered a high of $303300.0 during Q2 2025, and its lowest value of $3700.0 during Q4 2022.
  • Moreover, its 5-year median value for Revenue was $29000.0 (2022), whereas its average is $55405.3.
  • Per our database at Business Quant, BioRestorative Therapies' Revenue soared by 66091.21% in 2024 and then plummeted by 9494.86% in 2025.
  • Over the past 5 years, BioRestorative Therapies' Revenue (Quarter) stood at $5000.0 in 2021, then dropped by 26.0% to $3700.0 in 2022, then surged by 421.62% to $19300.0 in 2023, then skyrocketed by 124.35% to $43300.0 in 2024, then tumbled by 72.75% to $11800.0 in 2025.
  • Its last three reported values are $11800.0 in Q3 2025, $303300.0 for Q2 2025, and $25000.0 during Q1 2025.